Farms.com Home   News

Manitoba Canola Growers AGM Going Virtual Next Week

Manitoba Canola Growers will be hosting its AGM virtually on February 17th starting at 9am. The deadline to register is February 11th.

CLICK HERE TO REGISTER

The results of the Manitoba Canola Growers (MCGA) Election of Directors have been announced.

Five candidates were running for four positions with successful candidates being as follows:

Warren Ellis – Wawanesa
Charles Fossay – Starbuck
Pam Bailey – Dacotah
Jackie Dudgeon – Morden

“We are excited to share that more than 1000 members submitted their vote to determine the future direction of the MCGA board,” said Executive Director Delaney Ross Burtnack, “We welcome back our incumbent directors, and look forward to having two new directors at the table. It is great to see that our members share MCGA’s goal to see diversification of farmers on our board, and the perspectives they bring on important canola issues.”

Manitoba Canola Growers holds an election every two years, with four positions up for election each time.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.